< Back to search trials

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants

  • Clinicaltrials.gov #: NCT03776136
  • Acronym: LEAP 4
  • Tumor Type: Melanoma
  • Tumor Subtype: N/A
  • Tumor Stage: III/IV
  • Type of Treatment: